Efranat Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://efranat.com
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Phase 1
- Conditions
- Recurrent Respiratory Papillomatosis
- Interventions
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2016-08-03
- Lead Sponsor
- Efranat Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT02854761
Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- Efranat Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02052492
- Locations
- 🇮🇱
Sheba Medical Center, Ramat-Gan, Israel
🇮🇱Rambam MC, Haifa, Israel
© Copyright 2025. All Rights Reserved by MedPath